A Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo
Clinical trial NCT06625177 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06625177
- Sponsor
- Teva Branded Pharmaceutical Products R&D LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-11
- Primary completion
- 2026-09-18
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.